BIOMAT Database Logo BIOMAT Database Logo

Xenogeneic cellular immune responses and the control of microscopic tumor. A model. 1982

T J Smith, and P H Sugarbaker

Regimens for the generation of a highly cytotoxic xenogeneic response, the mechanism of this response, and its effect on tumor cells were investigated in a rat antimouse tumor system. Fischer 344 rats were immunized with EL-4 lymphoma and the ability of the sensitized rat lymphocytes to suppress the local growth of four different C57BL/6 tumors was evaluated. Optimal sensitization of the rat was achieved using large numbers of viable tumor cells in a primary intraperitoneal immunization. Highly cytotoxic effector cells generated in this xenogeneic setting significantly suppressed the local growth of appropriate tumor targets. Rat T cells appeared to be the sole effector cell and their effect was abrogated by anti-rat immune responses in the host mouse. This rat anti-EL-4 model with allow further investigation into xenogeneic antitumor responses and their possible role in local immunotherapy.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

T J Smith, and P H Sugarbaker
Cellular studies for in vitro modeling of xenogeneic immune responses.
January 2012, Methods in molecular biology (Clifton, N.J.),
T J Smith, and P H Sugarbaker
CD39 and control of cellular immune responses.
March 2007, Purinergic signalling,
T J Smith, and P H Sugarbaker
Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA.
July 1976, Journal of the National Cancer Institute,
T J Smith, and P H Sugarbaker
Injection of xenogeneic cells into teleost fish elicits systemic and local cellular innate immune responses.
October 2006, Cell and tissue research,
T J Smith, and P H Sugarbaker
ITIM-dependent negative signaling pathways for the control of cell-mediated xenogeneic immune responses.
January 2013, Xenotransplantation,
T J Smith, and P H Sugarbaker
Cellular early immune recognition of xenogeneic vascular endothelium.
April 1992, Transplantation proceedings,
T J Smith, and P H Sugarbaker
A cellular automata model of tumor-immune system interactions.
April 2006, Journal of theoretical biology,
T J Smith, and P H Sugarbaker
In vitro comparison of human xenogeneic and allogeneic proliferative cellular immune responses using serum-free media.
April 1996, Transplantation proceedings,
T J Smith, and P H Sugarbaker
Absence of immune responses with xenogeneic collagen and elastin.
July 2013, Tissue engineering. Part A,
T J Smith, and P H Sugarbaker
Murine xenogeneic immune responses to the human testis: a presumed immune-privileged tissue.
March 2000, Transplantation,
Copied contents to your clipboard!